Many people with diabetes get their cancer diagnosis too late
A significant study by the International Agency for Research on Cancer has shed light on the relationship between type 2 diabetes and cancer diagnosis.
The...
This diabetes drug can protect heart health in millions
A groundbreaking study from Yale reveals the potential of Semaglutide, known by the brand name Wegovy, in significantly reducing heart attack risks and other...
Many people type 2 diabetes test their blood sugar too much
A study from the University of Michigan reveals that a significant portion of Americans with type 2 diabetes may be testing their blood sugar...
Diabetes drug shows promise in protecting kidney health
A recent study from the University Medical Center Groningen has brought promising news for individuals suffering from chronic kidney disease (CKD), a condition where...
Promising drug lowers kidney failure risk for people with type 2 diabetes
Individuals with type 2 diabetes who also suffer from kidney disease face an exceptionally high risk of kidney failure, heart attacks, strokes, and death.
Researchers...
Low income is linked to high blood pressure, while high income is linked to...
A recent study published in Annals of Internal Medicine found that lower-income status was associated with an increased risk for hypertension compared to other...
New hydrogel drug delivery methods can treat diabetes and obesity better
Researchers at Stanford University have developed a novel hydrogel drug delivery system that can transform daily or weekly injections of diabetes and weight control...
Examining mental health and reducing stigma in diabetes
According to the Centers for Disease Control and Prevention, diabetes affects over 37 million people in the United States alone.
And mental health and stigma...
Widely used diabetes drug may cause infection disease, study finds
Sodium-glucose cotransporter-2 (SGLT2) inhibitors have become a valuable addition to the arsenal of medications for diabetes management.
However, a recent study conducted by the FDA...
Metformin may slow cognitive decline, reduce dementia risk in type 2 diabetes
Metformin, a widely used medication for managing blood sugar levels in individuals with type 2 diabetes, has shown promise in slowing cognitive decline and...